Aggressive chronic prostatitis mimicking locally advanced prostate cancer with apparent extraprostatic extension: a case report Authors: Ozkan Ozdemir Published: 2026 ABSTRACT AbstractBackgroundMultiparametric prostate MRI (mpMRI) is widely used for prostate cancer detection and local staging. Imaging features such as marked diffusion restriction, intense contrast enhancement, and apparent extraprostatic extension are typically associated with aggressive malignancy. However, inflammatory conditions may rarely mimic locally advanced prostate cancer, potentially leading to overstaging and inappropriate treatment.Case presentationA 49-year-old man presented with nonspecific lower urinary tract symptoms and a serum prostate-specific antigen level of 2.7 ng/mL. mpMRI revealed a large mass-like peripheral zone lesion with marked diffusion restriction, rapid early enhancement, and imaging features suggestive of extraprostatic extension, leading to a PI-RADS 5 assessment and suspicion of locally advanced prostate cancer. Despite aggressive imaging findings, systematic biopsy demonstrated chronic prostatitis without malignancy. Following antibiotic therapy, short-term follow-up mpMRI showed marked regression of the lesion with resolution of diffusion restriction and contrast enhancement, confirming an inflammatory etiology.ConclusionsAggressive chronic prostatitis may closely mimic locally advanced prostate cancer on mpMRI, including apparent extraprostatic extension. Recognition of this diagnostic pitfall and careful radiologic–clinical correlation are essential to avoid overstaging and unnecessary definitive treatment.Keywords: Chronic prostatitis, Prostate cancer mimic, Multiparametric MRI, Extraprostatic extension, PI-RADS Background Multiparametric magnetic resonance imaging (mpMRI) has become an integral component of contemporary prostate cancer detection, localization, and local staging pathways [1, 2]. The Prostate Imaging Reporting and Data System (PI-RADS) provides a standardized framework for interpretation, improving diagnostic consistency and risk stratification [1, 2]. Imaging findings such as marked diffusion restriction, early contrast enhancement, and signs of extraprostatic extension are commonly interpreted as indicators of clinically significant and potentially aggressive disease [3–5]. Diffusion-weighted imaging (DWI) plays a central role in prostate cancer assessment, as reduced apparent diffusion coefficient (ADC) values are associated with increased tumor cellularity and higher Gleason grade [6, 7]. Similarly, dynamic contrast-enhanced (DCE) MRI may demonstrate rapid early enhancement patterns that support suspicion of malignancy, although its specificity is limited [2, 8]. When these imaging features coexist with apparent capsular irregularity or tumor capsular contact suggestive of extraprostatic extension, the likelihood of locally advanced prostate cancer is typically considered high [4, 5]. Despite its high diagnostic performance, mpMRI is not immune to false-positive interpretations. Several benign conditions, including inflammatory processes, may mimic prostate cancer on imaging [9]. Chronic prostatitis most commonly presents with diffuse or ill-defined abnormalities; however, focal and mass-like inflammatory presentations have been described and may overlap substantially with imaging characteristics of malignancy [9–11]. Inflammatory infiltration and periprostatic reaction may obscure normal capsular anatomy, occasionally simulating extraprostatic extension and leading to potential overstaging [9, 12]. Recognition of these uncommon but clinically relevant imaging pitfalls is essential. Misinterpretation may result in unnecessary biopsy procedures, psychological distress, or even inappropriate definitive treatment strategies [4, 5]. Careful integration of radiologic findings with clinical parameters and histopathologic confirmation remains critical, particularly in cases with radiologic–clinical discordance [13]. Herein, we report a case of aggressive chronic prostatitis that closely mimicked locally advanced prostate cancer on mpMRI, including imaging features suggestive of extraprostatic extension, and highlight the importance of cautious interpretation and short-term follow-up imaging in selected patients. Case presentation A 49-year-old man presented with nonspecific lower urinary tract symptoms. There was no history of prior prostate biopsy, urinary tract infection, or systemic inflammatory disease. Digital rectal examination revealed grade 1 diffuse firmness of the prostate without discrete nodularity or tenderness. Serum prostate-specific antigen (PSA) level was 2.7 ng/mL. Given persistent symptoms, pelvic ultrasonography was performed and demonstrated a 47 × 35 mm heterogeneous hypoechoic mass-like lesion in the left posterior aspect of the prostate, causing contour irregularity with apparent extension beyond the prostatic margin, prompting further evaluation with mpMRI. mpMRI was performed on a 3.0 T scanner (SIGNA Pioneer, GE Healthcare, Waukesha, WI, USA) using a standardized prostate imaging protocol, including axial, sagittal, and coronal T2-weighted imaging, DWI with ADC mapping, and DCE sequences, in accordance with PI-RADS v2.1 technical recommendations [2, 14]. DWI was acquired with b-values of 50, 1000, and 1400 s/mm². The ADC map was calculated from the b = 50 and b = 1000 s/mm² acquisitions, while the b = 1400 s/mm² image set was obtained separately for visual high b-value assessment. The prostate gland measured 53 × 52 × 36 mm (transverse × anteroposterior × craniocaudal) on MRI, with an estimated volume of approximately 52 mL. Imaging revealed a large, ill-defined lesion involving the left posterolateral peripheral zone with extension toward adjacent periprostatic tissues. On T2-weighted images, the lesion appeared markedly hypointense with distortion of normal zonal anatomy (Fig. 1A). DWI demonstrated pronounced hyperintensity on high b-value images with corresponding low signal intensity on the ADC map, indicating marked diffusion restriction (Fig. 1B, C). Quantitative ADC measurement on the calculated ADC map yielded a value of 575 × 10⁻⁶ mm²/s within the lesion, consistent with marked diffusion restriction and falling well below the commonly referenced threshold for clinically significant prostate cancer suspicion. Restricted diffusion is a key imaging feature of clinically significant prostate cancer and correlates with increased cellularity [6, 7]. Baseline multiparametric prostate MRI findings. A Axial T2-weighted image shows a large ill-defined hypointense mass-like lesion in the left posterolateral prostate, extending toward the rectum with loss of normal glandular architecture (arrow). B High b-value diffusion-weighted image demonstrates marked hyperintensity within the lesion (arrow). C Apparent diffusion coefficient map shows corresponding low signal intensity, indicating restricted diffusion (arrow). D Dynamic contrast-enhanced MRI early phase demonstrates diffuse and intense enhancement throughout the lesion (arrow) DCE imaging demonstrated diffuse and intense early enhancement on dynamic sequences (Fig. 1D), followed by a plateau-type time–intensity curve with mild delayed washout (Fig. 2). Although such enhancement kinetics are frequently associated with malignancy, they are not entirely specific [2, 8]. Dynamic contrast-enhanced MRI time–intensity curve. Dynamic contrast-enhanced MRI time–intensity curve obtained from the lesion, based on signal intensity measurements acquired at 21-second intervals from 0 to 240 s, demonstrating rapid wash-in followed by a plateau with mild delayed wash-out The lesion demonstrated irregular margins with apparent capsular disruption and extension into adjacent periprostatic fat, raising strong concern for extraprostatic extension. MRI features suggestive of extraprostatic extension, including capsular irregularity and tumor–capsule contact, are considered important indicators of locally advanced disease and directly influence clinical staging and management decisions [4, 5]. Based on these imaging findings, the lesion was categorized as PI-RADS 5 [1, 15]. Despite the aggressive radiologic appearance, clinical parameters were discordant with advanced malignancy, particularly given the patient’s age and relatively modest PSA level. Systematic transrectal ultrasound-guided prostate biopsy was performed. Histopathologic evaluation revealed chronic inflammatory changes characterized by lymphoplasmacytic infiltration and stromal fibrosis, without evidence of malignancy. The patient was treated conservatively with antibiotic therapy. Short-term follow-up mpMRI demonstrated marked regression of the previously identified lesion, with substantial reduction in size, resolution of diffusion restriction, and decreased contrast enhancement (Fig. 3a-d). The previously suspected extraprostatic extension was no longer evident. The interval regression strongly supported an inflammatory etiology and excluded prostate cancer. Follow-up multiparametric prostate MRI findings after antibiotic therapy. A Axial T2-weighted image demonstrates a marked reduction in lesion size with partial restoration of normal prostatic architecture (arrow). B Axial diffusion-weighted image shows substantial decrease in diffusion restriction, with mild residual hyperintensity within the affected region (arrow). C Apparent diffusion coefficient map reveals corresponding increase in signal intensity compared with baseline, indicating improvement of diffusion restriction, with minimal residual low signal (arrow). D Dynamic contrast-enhanced MRI demonstrates reduced and less enhancement compared with baseline, with focal residual enhancement persisting (arrow) Patient perspective The patient expressed significant anxiety after being informed of the initial suspicion of advanced prostate cancer based on imaging findings. Following biopsy results and subsequent regression of the lesion after treatment, he reported relief and appreciation for the cautious diagnostic approach that avoided unnecessary radical intervention. Discussion and conclusions This case illustrates a clinically significant diagnostic pitfall in mpMRI, in which aggressive chronic prostatitis closely mimicked locally advanced prostate cancer, including imaging features suggestive of extraprostatic extension. Although mpMRI has substantially improved prostate cancer detection and staging accuracy, false-positive interpretations remain an important limitation in selected scenarios [13, 16]. DWI is central to prostate cancer detection and risk stratification. Low ADC values are commonly associated with increased tumor cellularity and higher histologic grade [6, 7]. However, restricted diffusion is not specific to malignancy. Dense inflammatory infiltrates, stromal edema, and hypercellular benign conditions may produce similarly low ADC values, particularly in focal or mass-forming inflammatory processes [9, 11]. Notably, markedly low ADC values may also be encountered in highly cellular or purulent inflammatory processes, where dense inflammatory infiltration and restricted extracellular water mobility produce pronounced diffusion restriction that may further overlap with imaging features of clinically significant malignancy. Previous studies have demonstrated substantial overlap in diffusion characteristics between prostate cancer and inflammatory lesions, limiting specificity in certain clinical contexts [8]. While inflammatory mimics of prostate cancer have been previously acknowledged in the mpMRI literature, the present case extends these observations in several clinically meaningful respects. Prior reports have largely focused on granulomatous prostatitis — including BCG-induced and nonspecific granulomatous subtypes — as the predominant aggressive inflammatory mimic, with apparent extraprostatic extension typically limited to capsular abutment rather than frank periprostatic invasion [16, 17]. Nonspecific chronic prostatitis, the far more common inflammatory entity, has been acknowledged as a potential source of false-positive mpMRI findings; however, its presentation as a dominant PI-RADS 5 lesion with frank apparent extraprostatic extension as the primary and most alarming imaging feature has not been specifically documented. Furthermore, no prior report has demonstrated marked radiologic regression on short-term follow-up mpMRI following antibiotic therapy as a non-invasive confirmatory strategy. The present case therefore fills a meaningful gap in the existing literature, illustrating that even the most aggressive inflammatory mpMRI presentations — indistinguishable from locally advanced malignancy — may resolve completely with conservative management when clinical and radiologic findings are discordant. DCE MRI further contributed to the initial suspicion of malignancy in this case. Rapid early enhancement and plateau-type curves are frequently associated with clinically significant prostate cancer [2, 8]. Nevertheless, inflammatory hyperemia and increased vascular permeability may generate comparable enhancement kinetics [8, 11]. Although DCE MRI is considered a supportive component within the PI-RADS framework, its limited specificity in isolation is well recognized [1, 2]. Concordant diffusion restriction and enhancement findings may therefore bias interpretation toward malignancy, particularly in visually aggressive lesions. The most clinically consequential pitfall in this case was the appearance of extraprostatic extension. MRI features such as capsular irregularity, tumor–capsule contact, and periprostatic fat involvement are critical determinants of local staging and directly influence treatment planning [4, 5]. While mpMRI demonstrates moderate to high specificity for detecting extraprostatic extension, false-positive findings are reported and remain a known limitation [4]. Inflammatory involvement of the capsule and adjacent tissues may obscure normal anatomic planes, simulating capsular breach and periprostatic invasion [9, 12]. Awareness that apparent extraprostatic extension may rarely occur in benign inflammatory conditions is essential to prevent overstaging. Radiologic–clinical discordance provided a key diagnostic clue in this patient. The relatively young age and modest prostate-specific antigen level were atypical for locally advanced disease. In such circumstances, histopathologic confirmation is mandatory before definitive treatment decisions are made [13]. Short-term follow-up mpMRI after conservative management may provide decisive diagnostic clarification. In the present case, marked interval regression of the lesion, with resolution of diffusion restriction and reduction in enhancement, confirmed an inflammatory etiology and effectively excluded malignancy. This case report has limitations inherent to single-patient observations. Histopathologic confirmation was based on systematic biopsy rather than radical prostatectomy specimens, and sampling error cannot be completely excluded. However, marked radiologic regression after antibiotic therapy strongly supports an inflammatory etiology. Larger series would be valuable to better characterize imaging patterns of aggressive inflammatory mimics and define distinguishing features from locally advanced malignancy. In conclusion, aggressive chronic prostatitis may rarely present as a mass-like lesion on mpMRI with marked diffusion restriction, intense contrast enhancement, and imaging features suggestive of extraprostatic extension, thereby closely simulating locally advanced prostate cancer. This case emphasizes that apparent extraprostatic extension on MRI should not be interpreted in isolation, particularly when clinical parameters are discordant. Integrating imaging findings with clinical context and ensuring histopathologic verification are essential to prevent overstaging and avoid unnecessary radical treatment. Increased awareness of this potential mimic may contribute to more cautious staging assessments and more individualized patient management strategies in prostate cancer imaging. Dynamic contrast-enhanced MRI time–intensity curve obtained from the lesion, based on signal intensity measurements acquired at 21-second intervals from 0 to 240 s, demonstrating rapid wash-in followed by a plateau with mild delayed wash-out. Acknowledgements Not applicable. Clinical trial number Not applicable. Abbreviations Multiparametric magnetic resonance imaging Diffusion-weighted imaging Apparent diffusion coefficient Dynamic contrast-enhanced Prostate Imaging Reporting and Data System Prostate-specific antigen Authors’ contributions The author was responsible for study conception, imaging interpretation, manuscript drafting, and final approval of the manuscript. Funding No funding was received for this work. Data availability All relevant data supporting the conclusions of this case report are included within the article. Declarations Ethics approval and consent to participate Ethical approval was not required for this case report according to institutional policy. Consent for publication Written informed consent was obtained from the patient for publication of this case report and accompanying images. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement All relevant data supporting the conclusions of this case report are included within the article.